Human obesity studies were also conducted during pharmaceutical development, but the largest reported placebo-controlled study did not demonstrate a statistically significant weight-loss benefit, and development for obesity was discontinued
The clinical data suggesting a possible association come from post-marketing surveillance data that have substantial risk for bias and do not control for important confounding variables
(2007) International Journal of Obesity In-vitro study demonstrating AOD 9604 stimulation of cartilage matrix synthesis and chondrocyte proliferation in osteoarthritic cultures
Supports energy production, reduces fatigue, and is especially important for patients with malabsorption or colitis
Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material